An imaging pilot study of 18F-fluoro-3'-deoxy-3'-L-fluorothymidine (18F-FLT) in patients with locally advanced or metastatic pancreatic cancer who will be treated with gemcitabine.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 28 Aug 2019 Biomarkers information updated
- 27 Oct 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 08 Nov 2007 The expected completion date for this trial is now 1 Nov 2012.